{"count": 1, "results": [{"_id": "25122066", "pmid": 25122066, "title": "Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.", "journal": "Mol Cancer Ther", "authors": ["Babcook MA", "Shukla S", "Fu P", "Vazquez EJ", "Puchowicz MA", "Molter JP", "Oak CZ", "MacLennan GT", "Flask CA", "Lindner DJ", "Parker Y", "Daneshgari F", "Gupta S"], "date": "2014-10-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-14-0451", "meta_date_publication": "2014 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "2288-302", "score": 50050.824, "text_hl": "Studies of @CELLLINE_CVCL:4787 @@@C4-2B4@@@ orthotopic NCr-nu/nu @SPECIES_10090 @@@mice@@@ further demonstrated that combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ (3.5-7.0 mug/g body weight @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 175-350 mug/g body weight @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@) daily by oral gavage over a 9-week period significantly inhibited primary ventral @DISEASE_Prostatitis @DISEASE_MESH:D011472 @@@prostate tumor@@@ formation, @<m>DISEASE_Cachexia</m> @DISEASE_MESH:D002100 @@@cachexia@@@, @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@bone metastasis@@@, and biochemical failure more effectively than 24 mug/g body weight @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@ intraperitoneally injected every 3 weeks, 7.0 mug/g/day @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, or 350 mug/g/day @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment alone, with significantly less @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ and mortality than @CHEMICAL_Docetaxel @CHEMICAL_MESH:D000077143 @@@docetaxel@@@, establishing combination of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ as a promising chemotherapeutic alternative for metastatic @DISEASE_Prostatic_Neoplasms_Castration_Resistant @DISEASE_MESH:D064129 @@@CRPC@@@.", "citations": {"NLM": "Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2288-302. PMID: 25122066", "BibTeX": "@article{25122066, title={Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.}, author={Babcook MA and Shukla S and Fu P and Vazquez EJ and Puchowicz MA and Molter JP and Oak CZ and MacLennan GT and Flask CA and Lindner DJ and Parker Y and Daneshgari F and Gupta S}, journal={Mol Cancer Ther}, volume={13}, number={10}, pages={2288-302}}"}}]}